FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

735231009: Sarilumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3513729019 Sarilumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3513730012 Sarilumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
54321000195110 sarilumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839451000172116 sarilumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
69481000195111 Sarilumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sarilumab (substance) Is a Interleukin receptor antagonist false Inferred relationship Some
Sarilumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Interleukin receptor antagonist (disposition) false Inferred relationship Some
Sarilumab (substance) Is a Immunologic agent (substance) true Inferred relationship Some
Sarilumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Sarilumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Interleukin 6 receptor antagonist (disposition) true Inferred relationship Some
Sarilumab (substance) Is a Interleukin 6 receptor antagonist true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing sarilumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sarilumab (substance) Inferred relationship Some 1
Sarilumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sarilumab (substance) Inferred relationship Some 1
Product containing only sarilumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sarilumab (substance) Inferred relationship Some 1
Product containing only sarilumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sarilumab (substance) Inferred relationship Some 1
Sarilumab 131.579 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sarilumab (substance) Inferred relationship Some 1
Sarilumab 131.579 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sarilumab (substance) Inferred relationship Some 1
Product containing precisely sarilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sarilumab (substance) Inferred relationship Some 1
Product containing precisely sarilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sarilumab (substance) Inferred relationship Some 1
Administration of sarilumab (procedure) Direct substance True Sarilumab (substance) Inferred relationship Some 1
Adverse reaction to sarilumab (disorder) Causative agent (attribute) True Sarilumab (substance) Inferred relationship Some 1
Sarilumab therapy (procedure) Direct substance True Sarilumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start